Skip to content

PENG Block Combined to Wound Infiltration for Hip Replacement

Pericapsular Nerve Group (PENG) Block Combined to Wound Infiltration vs. Wound Infiltration Alone for Postoperative Analgesia After Total Hip Replacement: a Prospective Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04306133
Enrollment
60
Registered
2020-03-12
Start date
2020-03-09
Completion date
2020-12-31
Last updated
2021-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain, Analgesia, Hip Arthropathy, Pain, Postoperative Complications, Postoperative Pain

Keywords

regional anesthesia, hip surgery, PENG

Brief summary

This study analyze the effect of Pericapsular Nerve Group (PENG) Block combined to wound infiltration for analgesia after elective hip replacement. Half of participants will receive a PENG Block combined with wound infiltration, while the other half will receive wound infiltration alone.

Interventions

PROCEDUREPENG block

After performing spinal anesthesia, PENG block with 20 mL of 0.375 % Ropivacaine will be executed as described by Giron-Arongo et al with a low frequency curvilinear probe. A 22G 80 mm needle (Stimuplex Ultra 360, Braun ) will be used.

PROCEDUREWound Infiltration

At the end of operation, the surgeon will perform wound infiltration with 20 mL of 0.375 % Ropivacaine.

Sponsors

Campus Bio-Medico University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective hip replacement surgery * ASA physical status score \< 4

Exclusion criteria

* Contraindications to regional anesthesia * ASA physical status score ≥ 4 * Patient's refusal or inability to sing the informed consent * Pre-operatively therapy with opioids * Allergies to any drug provided by the study protocol

Design outcomes

Primary

MeasureTime frameDescription
Maximum Pain Score24 hoursA visual analog pain scale anchored by no pain (score of 0) and pain as bad as it could be or worst imaginable pain (score of 100 \[100-mm scale\]) will be used to evaluate pain during 48 h after surgery
Total opioids consumption48 hoursTotal of Sublingual Sufentanil tablets released

Secondary

MeasureTime frameDescription
Time to ambulation48 hoursTime until the patient is able to stand up and walk with or without assistive devices
Quadriceps weakness48 hoursPresence of weakness of the quadriceps using a scale where 0= no effect; 1 = knee flexion possible but not hip flexion; 2 = absence of knee and hip flexion
Time to first opioid48 hoursTime (hours) from the end of surgery to the first opioid administration
Opioids side effects48 hoursThe presence or absence of opioids side effects such as drowsiness, desaturation, nausea and vomiting
Incidence of block complications48 hoursAny complications or side effects of the blocks, such as local infection, intravascular injection of local anesthetics and immediate systemic toxicity.
Range of hip motion24 hoursDegrees of hip flexion

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026